Veradigm reports flat 2025 revenue amid debt restructuring efforts

Veradigm Inc. (OTCMKTS: MDRX) reported preliminary fiscal 2025 revenue of $584 million to $589 million, representing a 1% decline from 2024's estimated range of $590 million to $595 million, according to a company statement.

The healthcare technology provider's cash position decreased significantly to $120 million as of December 31, 2025, compared to $294 million at the end of 2024. The $174 million reduction resulted primarily from debt refinancing activities, including repurchasing convertible notes for $229 million and borrowing $70 million under a new term loan facility.

Chief Executive Officer Donald Trigg outlined the company's strategic focus on what he termed a "Reset, Recover, Reignite" plan during his first 100 days in the role. "We have made progress on our work to 'get current and stay current' with our SEC filings," Trigg stated.

The company's debt structure changed substantially, with total debt declining to approximately $75 million from $208 million, consisting entirely of the senior secured term loan facility with a June 2030 maturity date. Additional cash outflows included $62 million for transaction and other expenses related to legal settlements, severance, and investigation costs.

Interim Chief Financial Officer Lee Westerfield noted that revenue performance remained steady and the company maintained positive net cash throughout 2025. The provider segment, which serves independent physician practices, generated $463 million to $467 million in revenue, while the payer and life science division contributed $121 million to $122 million.

Veradigm had 108.8 million shares of common stock outstanding and 11.6 million unvested restricted stock units as of December 31, 2025. The company plans to host an investor conference call on February 18, 2026, to discuss its business update and strategic initiatives.

You May Also Be Interested In

• Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
• Ferguson to acquire FloWorks for $1.6 billion in cash deal
• Jefferies Upgrades Friedrich Vorwerk Group SE (VH2:GR) to Hold